Trailing-twelve-month (TTM) revenue is $2.45 Billion with a year-over-year growth of (1.80%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-30 | $550,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q2 FY2026Period ended 2025-12-31 | $656,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q3 FY2026Period ended 2026-03-31 | $630,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q4 FY2026Period ended 2026-06-30 | $607,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $2,445,900,000 |
Current P/S: $2,058,660,917 market capitalization ÷ $2,445,900,000 TTM revenue = 0.84x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:00:24.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-30): $607.70M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:04:58.836Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| Product | $2.2B | N/A | $2.5B | $992M | $817M | $770M |
| Subscription and Circulation | N/A | $1.4B | $2.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| Non-US | $283M | $323M | $209M | $214M | $217M | $240M |
| North America | $3.7B | $3.3B | $2.6B | $2.5B |
$2.45B
$2.45 Billion
(1.80%)
vs. $2.49B a year ago (TTM)
(9.47%)
5 Year compound annual growth rate
1 Year
(1.80%)
3 Year
(4.41%)
5 Year
(9.47%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $2.45B | ($44.90M) | (1.80%) |
| 2025 | $2.49B | ($209.70M) | (7.77%) |
| 2024 | $2.70B | ($99.70M) | (3.56%) |
| 2023 | $2.80B | ($782.00M) | (21.83%) |
| 2022 | $3.58B | ($439.60M) | (10.93%) |
| 2021 |
TTM Growth
(1.80%)
3-Year CAGR
(4.41%)
5-Year CAGR
(9.47%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 30 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T18:04:58.836Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.7B |
| $1.7B |
| $1.7B |
| $2.2B |
| $4.02B |
| +$2.20B |
| +120.26% |
| 2020 | $1.83B | +$910.90M | +99.55% |
| 2019 | $915.00M | +$480.00M | +110.34% |
| 2018 | $435.00M | +$216.40M | +98.99% |
